Article
Usefulness of Hemoglobin A1c to Predict Outcome After Cardiac Resynchronization Therapy in Patients With Diabetes Mellitus and Heart Failure
American Journal of Cardiology
(2012)
Disciplines
Publication Date
September 1, 2012
DOI
10.1016/j.amjcard.2012.04.056
Citation Information
Ravi V. Shah, Robert K. Altman, Mi Young Park, Jodi Zilinski, et al.. "Usefulness of Hemoglobin A1c to Predict Outcome After Cardiac Resynchronization Therapy in Patients With Diabetes Mellitus and Heart Failure" American Journal of Cardiology Vol. 110 Iss. 5 (2012) p. 683 - 688 Available at: http://works.bepress.com/jodi-zilinski/2/